Total Payments
$512.05
2024 Payments
$237.18
Companies
7
Transactions
23
Medicare Patients
1,448
Medicare Billing
$80,656
Payment Breakdown by Category
Food & Beverage$512.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $512.05 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $269.61 | 14 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $109.29 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $70.47 | 4 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $23.54 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $13.75 | 1 | $0 (2021) |
| Genentech USA, Inc. | $12.97 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $12.42 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.18 | 12 | PFIZER INC. ($213.64) |
| 2023 | $55.97 | 3 | PFIZER INC. ($55.97) |
| 2021 | $26.72 | 2 | GlaxoSmithKline, LLC. ($13.75) |
| 2019 | $57.03 | 3 | Janssen Pharmaceuticals, Inc ($57.03) |
| 2018 | $13.44 | 1 | Janssen Pharmaceuticals, Inc ($13.44) |
| 2017 | $121.71 | 2 | SANOFI-AVENTIS U.S. LLC ($109.29) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/15/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/18/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/26/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/22/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/23/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Virology & Specialty Care | ||||||
| 03/12/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: VACCINES | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Cardiovascular | ||||||
| 09/26/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $109.29 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 467 | 534 | $71,285 | $24,238 |
| 2022 | 14 | 589 | 817 | $94,704 | $30,710 |
| 2021 | 7 | 357 | 384 | $68,403 | $24,136 |
| 2020 | 1 | 35 | 38 | $22,952 | $1,572 |
Total Patients
1,448
Total Services
1,773
Medicare Billing
$80,656
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 138 | $29,394 | $8,410 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $13,952 | $4,880 | 35.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 80 | 86 | $8,858 | $3,487 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $5,232 | $2,356 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,770 | $2,297 | 48.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 34 | 69 | $3,519 | $1,119 | 31.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 59 | 60 | $2,667 | $968.00 | 36.3% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 12 | 12 | $896.00 | $240.58 | 26.9% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 12 | 12 | $916.00 | $213.43 | 23.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $561.00 | $178.20 | 31.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 40 | $520.00 | $88.00 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 187 | $39,831 | $12,138 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $19,402 | $5,541 | 28.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 70 | 72 | $7,416 | $2,921 | 39.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 55 | 55 | $8,305 | $2,811 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 22 | $4,796 | $2,224 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,180 | $1,779 | 55.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 42 | 81 | $4,131 | $1,320 | 32.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $2,769 | $776.66 | 28.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 23 | 23 | $1,147 | $363.07 | 31.7% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 16 | 18 | $1,344 | $347.82 | 25.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 14 | 14 | $714.00 | $227.77 | 31.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 18 | $828.00 | $151.16 | 18.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 38 | 43 | $559.00 | $95.48 | 17.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 16 | 170 | $282.00 | $12.78 | 4.5% |
About Dr. Nghia Phan, DO
Dr. Nghia Phan, DO is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831117233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nghia Phan, DO has received a total of $512.05 in payments from pharmaceutical and medical device companies, with $237.18 received in 2024. These payments were reported across 23 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($512.05).
As a Medicare-enrolled provider, Phan has provided services to 1,448 Medicare beneficiaries, totaling 1,773 services with total Medicare billing of $80,656. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 07/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1831117233
Products in Payments
- PAXLOVID (Drug) $269.61
- TOUJEO (Drug) $109.29
- XARELTO (Drug) $70.47
- AIRSUPRA (Drug) $23.54
- BEXSERO (Biological) $13.75
- Xofluza (Drug) $12.97
- ELIQUIS (Drug) $12.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Emergency Medicine $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Emergency Medicine $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Emergency Medicine $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
Emergency Medicine $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Emergency Medicine $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507
Emergency Medicine $1,507